For a limited time, The Motley Fool Australia is giving away an urgent new investment report outlining our 5 favourite stocks for investors over 50. Each company boasts strong growth prospects over the next 3 to 5 years, and most importantly each pays a generous (and fully franked) dividend! So if you’re looking to get your finances on track and you’re in or near retirement – we’ve got you covered!
Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
About CannPal Animal Therapeutics Ltd (ASX: CP1)
CannPal Animal Therapeutics Ltd is an animal-focused pharmaceutical company. It is engaged in developing standardized and dosage controlled, regulatory approved pharmaceuticals, derived from the cannabis plant. The company is intended for developing cannabinoid-based therapeutics with an initial focus on cats, dogs, and horses.